Studies have shown that active fund managers routinely underperform the S&P500 index*​

ProMIS Neurosciences, Inc. (NASDAQ: PMN)

PMN Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
37.30%

PMN Stock Analysis

PMN PE Ratio:

PMN PEG Ratio: Not Available

PMN Forward EPS Growth (12 month): 0.00%

PMN PS Ratio:

PMN PSG Ratio: Not Available

PMN Forward Revenue Growth (12 month): 0.00%

PMN Articles

No data was found